However, in another HCC model as well as in a triple-negative breast cancer model, the tumor-suppressive effect of sitagliptin could not be traced back to the CXCR3 chemokine cleavage, but was instead dependent on a CCL11-mediated higher eosinophilic infiltration [142]. This evidence concerns the gene CXCR3 and hepatocellular carcinoma.